Moreover, upon the creation of an ALG3-overexpression model, previously radiosensitive breast cancer cell lines demonstrated radioresistance, and ALG3-overexpressing breast cancer cell lines, when injected subcutaneously into mice, displayed an increased tumor growth rate and OCT4 gene expression (a commonly used marker to assess CSC enrichment). This evidence concerns the gene ALG3 and breast carcinoma.